Saudi German Hospital-Dubai Implements Omnicell Automated Medication Management Solutions

Top-rated Facility Looking to Improve Workflow Efficiency

MOUNTAIN VIEW, California, March 27, 2017 /PRNewswire/ — Omnicell, Inc. (NASDAQ: OMCL) today announced that Saudi German Hospital-Dubai has implemented its medication management solutions to improve workflow efficiency, give clinicians more time to spend with patients, and help provide better healthcare services. Saudi German Hospital-Dubai is part of the largest private hospital group in the Middle East. With 165 beds, the facility offers a wide range of medical services—including a variety of specialties, sub-specialties and critical care.


The Omnicell technology will help to streamline provider workflows while helping to ensure the highest level of safety for the hospital’s international clientele. In order to secure safe storage and distribution of medications on hospital floors and in operating rooms, Saudi German Hospital-Dubai has implemented Omnicell® automated dispensing cabinets and Anesthesia Workstation. Omnicell robotic dispensing systems—consisting of the Medimatstorage and dispensing unit and the Speedbox filling system—will help the facility increase pharmacy operations and help enable safer, quicker and more efficient dispensing with reduced human errors.

“Implementing the Omnicell outpatient robotic dispensing solution and automated dispensing cabinets is a step toward achieving our vision of becoming the premier healthcare provider in the MENA region. It enables us to provide a higher standard of service by giving clinicians more time for patient care,” said Dr. Reem Osman, CEO of Saudi German Hospital-Dubai. “Omnicell solutions not only increase our workflow efficiency, but also ensure we provide the highest standard of service to our patients. Our partnership with Omnicell is aligned with our commitment to providing superior clinical services that add value to our patients, their families and our community as a whole.”

“We are pleased to welcome a hospital with such an impeccable reputation to the Omnicell family and are proud to support Saudi German Hospital-Dubai’s mission to deliver high-quality, compassionate care by implementing the latest technology throughout their facility,” said Tamer Elsarnagawy, director of business development MEA at Omnicell.

About Saudi German Hospital-Dubai

Saudi German Hospital-Dubai is part of the largest private hospital group in the Middle East. SGH-Dubai started in March 2012 as the 6th tertiary care hospital in the SGH Group, and is now considered one of the major tertiary care hospitals in Dubai and UAE.

The SGH team is committed to providing superior clinical services that add value to patients, their families, SGH stakeholders, and the community as a whole. SGH-Dubai aims to become the premier healthcare provider and the employer of choice, drawing the best talent in the MENA region.

About Omnicell

Since 1992, Omnicell (NASDAQ: OMCL) has been inspired to create safer and more efficient ways to manage medications and supplies across all care settings. As a leader in medication and supply dispensing automation, central pharmacy automation, IV robotics, analytics software, and medication adherence and packaging systems, Omnicell is focused on improving care across the entire healthcare continuum—from the acute care hospital setting, to post-acute skilled nursing and long-term care facilities, to the patient’s home.

Over 4,000 customers worldwide use Omnicell® automation and analytics solutions to increase operational efficiency, reduce medication errors, deliver actionable intelligence and improve patient safety.

Omnicell’s innovative medication adherence solutions, used by over 32,000 institutional and retail pharmacies in North America and the United Kingdom, are designed to improve patient adherence to prescriptions, helping to reduce costly hospital readmissions.

Recent Omnicell acquisitions, including Ateb, add distinct capabilities, particularly in central pharmacy, IV robotics, and pharmacy software, creating the broadest medication management product portfolio in the industry.

For more information about Omnicell, Inc. please visit


Editor’s Notes:

  1. All Omnicell news releases (financial, acquisitions, products, technology etc.) are issued exclusively by PR Newswire and are immediately thereafter posted on the company’s external website,
  2. Omnicell and the Omnicell logo design are registered trademarks of Omnicell, Inc.
  3. All other brand or product names may be trademarks or registered trademarks of their respective companies.

Logo –